Skip to main content
Caplight Logo









Distalmotion

Distalmotion

Private
EpalingesHealthcare & Life Scienceshttps://distalmotion.com

Last Round

Debt

Oct 21, 2026

Total Funding Raised

$460M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Distalmotion operates in Healthcare & Life Sciences and is based in Epalinges. Its latest recorded funding round was a Debt round in October 2026.

Distalmotion is a medical technology company that develops surgical robotic systems aimed at simplifying surgical procedures through minimally invasive techniques for dissection and suturing in the abdominal cavity.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Distalmotion Comparables

Compare Distalmotion with similar companies based on industry and business-model similarity.

Distalmotion comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Levita Magnetics
85%
Virtual Incision
83%
CMR Surgical
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Distalmotion Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtOct 21, 2026
IPOMar 22, 2026
StrategicJan 13, 2026
Series GNov 18, 2025
VC RoundSep 13, 2024
Series F
Apr 19, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Greg Roche

Chief Executive Officer

Executive Team

Lionel Flaction

Chief Technology Officer

Executive Team

Romain Farkas

Chief Technology Officer

Executive Team

Frank Schulkes

Chief Financial Officer, Non Executive Director

Executive Team

For institutional investors. Book with your work email.

Distalmotion Investors

Notable investors and investment history

Distalmotion investors
InvestorRounds
EuroUS VenturesSeries F
Perceptive AdvisorsDebt
415Series E
415 CapitalSeries E
Revival Healthcare CapitalSeries F, Series G, VC Round, Series E
Zühlke VenturesSeries A
Helvetica CapitalVC Round
Book a demo to see all 10 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 21, 2026

    $70M round led by Perceptive Advisors.

  • Apr 20, 2026

    DEXTER robotic surgical system now commercially available in US and Europe.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • recognized_asOct 23, 2026

    Distalmotion is a multiple-time Top100 Swiss Startup Ranking company and a Venture Kick and Venture Leaders alumnus.

  • is_developingOct 23, 2026

    On Oct 23rd '26 in the United States, Distalmotion continues developing the DEXTER Robotic Surgery System with up to USD 70 million in financing from Perceptive Advisors, supporting ASC expansion and the system's instrument portfolio.

  • is_developingOct 21, 2026

    Distalmotion develops the commercially available DEXTER platform to expand access to robotic-assisted minimally invasive surgery through a mobile system that integrates with existing operating rooms for hospitals, hospital outpatient departments, and ambulatory surgery centers.

  • receives_financingOct 21, 2026

    On Oct 21st '26 in Switzerland, Distalmotion enters into a senior secured term loan facility of up to $70M with Perceptive Advisors to support its US ambulatory surgery center market expansion and further development of the DEXTER Robotic Surgery System and instrument portfolio.

Book a demo to see all news

For institutional investors. Book with your work email.

Distalmotion Filings

Explore SEC and related filing metadata, where available.

Distalmotion filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Distalmotion's valuation, stock price, and market status.

Is Distalmotion a public or private company?

Distalmotion is a private company.

What is the current stock price of Distalmotion?

Distalmotion is a private company, so its shares have no public market price. Caplight tracks Distalmotion's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Distalmotion worth (valuation)?

Valuation information for Distalmotion is not publicly available.

Can I buy Distalmotion stock?

Distalmotion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Distalmotion's last funding round?

Distalmotion's most recent funding round was Debt on October 21, 2026.

Who are the main investors in Distalmotion?

Key investors in Distalmotion include Revival Healthcare Capital, Zühlke Ventures, Blue Ocean Ventures.

Will Distalmotion IPO soon?

No public IPO plans have been announced for Distalmotion.

How can I track Distalmotion secondary market activity?

Caplight tracks bids, offers, and trades in Distalmotion's shares on secondary markets.

Firmographic Details

HeadquartersEpalinges
Employee Range219
Year Founded2012
Last FundingOct 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?